179 related articles for article (PubMed ID: 32752908)
1. Development of freeze-drying cycle via design space approach: a case study on vaccines.
Scutellà B; Bourlès E
Pharm Dev Technol; 2020 Dec; 25(10):1302-1313. PubMed ID: 32752908
[TBL] [Abstract][Full Text] [Related]
2. The nonsteady state modeling of freeze drying: in-process product temperature and moisture content mapping and pharmaceutical product quality applications.
Pikal MJ; Cardon S; Bhugra C; Jameel F; Rambhatla S; Mascarenhas WJ; Akay HU
Pharm Dev Technol; 2005; 10(1):17-32. PubMed ID: 15776810
[TBL] [Abstract][Full Text] [Related]
3. Optimizing lyophilization primary drying: A vaccine case study with experimental and modeling techniques.
Najarian J; Metsi-Guckel E; Renawala HK; Grosse D; Sims A; Walter A; Sarkar A; Karande A
Int J Pharm; 2024 Jun; 659():124168. PubMed ID: 38663644
[TBL] [Abstract][Full Text] [Related]
4. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
[TBL] [Abstract][Full Text] [Related]
5. Use of a temperature ramp approach (TRA) to design an optimum and robust freeze-drying process for pharmaceutical formulations.
Assegehegn G; Brito-de la Fuente E; Franco JM; Gallegos C
Int J Pharm; 2020 Mar; 578():119116. PubMed ID: 32027958
[TBL] [Abstract][Full Text] [Related]
6. Freeze drying of L-arginine/sucrose-based protein formulations, part I: influence of formulation and arginine counter ion on the critical formulation temperature, product performance and protein stability.
Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
J Pharm Sci; 2015 Jul; 104(7):2345-58. PubMed ID: 25994980
[TBL] [Abstract][Full Text] [Related]
7. Fundamentals of freeze-drying.
Nail SL; Jiang S; Chongprasert S; Knopp SA
Pharm Biotechnol; 2002; 14():281-360. PubMed ID: 12189727
[TBL] [Abstract][Full Text] [Related]
8. Impact of dextran on thermal properties, product quality attributes, and monoclonal antibody stability in freeze-dried formulations.
Haeuser C; Goldbach P; Huwyler J; Friess W; Allmendinger A
Eur J Pharm Biopharm; 2020 Feb; 147():45-56. PubMed ID: 31866444
[TBL] [Abstract][Full Text] [Related]
9. Formulation approach for the development of a stable, lyophilized formaldehyde-containing vaccine.
Clausi A; Chouvenc P
Eur J Pharm Biopharm; 2013 Oct; 85(2):272-8. PubMed ID: 23673385
[TBL] [Abstract][Full Text] [Related]
10. Uncertainty analysis as essential step in the establishment of the dynamic Design Space of primary drying during freeze-drying.
Mortier STFC; Van Bockstal PJ; Corver J; Nopens I; Gernaey KV; De Beer T
Eur J Pharm Biopharm; 2016 Jun; 103():71-83. PubMed ID: 26992290
[TBL] [Abstract][Full Text] [Related]
11. Modelling the primary drying step for the determination of the optimal dynamic heating pad temperature in a continuous pharmaceutical freeze-drying process for unit doses.
De Meyer L; Lammens J; Mortier STFC; Vanbillemont B; Van Bockstal PJ; Corver J; Nopens I; Vervaet C; De Beer T
Int J Pharm; 2017 Oct; 532(1):185-193. PubMed ID: 28887221
[TBL] [Abstract][Full Text] [Related]
12. Using dextran of different molecular weights to achieve faster freeze-drying and improved storage stability of lactate dehydrogenase.
Larsen BS; Skytte J; Svagan AJ; Meng-Lund H; Grohganz H; Löbmann K
Pharm Dev Technol; 2019 Mar; 24(3):323-328. PubMed ID: 29781745
[TBL] [Abstract][Full Text] [Related]
13. Fast freeze-drying cycle design and optimization using a PAT based on the measurement of product temperature.
Bosca S; Barresi AA; Fissore D
Eur J Pharm Biopharm; 2013 Oct; 85(2):253-62. PubMed ID: 23631849
[TBL] [Abstract][Full Text] [Related]
14. Optimization of a pharmaceutical freeze-dried product and its process using an experimental design approach and innovative process analyzers.
De Beer TR; Wiggenhorn M; Hawe A; Kasper JC; Almeida A; Quinten T; Friess W; Winter G; Vervaet C; Remon JP
Talanta; 2011 Feb; 83(5):1623-33. PubMed ID: 21238761
[TBL] [Abstract][Full Text] [Related]
15. Application of Optical Coherence Tomography Freeze-Drying Microscopy for Designing Lyophilization Process and Its Impact on Process Efficiency and Product Quality.
Korang-Yeboah M; Srinivasan C; Siddiqui A; Awotwe-Otoo D; Cruz CN; Muhammad A
AAPS PharmSciTech; 2018 Jan; 19(1):448-459. PubMed ID: 28785859
[TBL] [Abstract][Full Text] [Related]
16. Freeze drying of nanosuspensions, 2: the role of the critical formulation temperature on stability of drug nanosuspensions and its practical implication on process design.
Beirowski J; Inghelbrecht S; Arien A; Gieseler H
J Pharm Sci; 2011 Oct; 100(10):4471-81. PubMed ID: 21607957
[TBL] [Abstract][Full Text] [Related]
17. Quality by design: optimization of a freeze-drying cycle via design space in case of heterogeneous drying behavior and influence of the freezing protocol.
Pisano R; Fissore D; Barresi AA; Brayard P; Chouvenc P; Woinet B
Pharm Dev Technol; 2013 Feb; 18(1):280-95. PubMed ID: 23078169
[TBL] [Abstract][Full Text] [Related]
18. Impact of fast and conservative freeze-drying on product quality of protein-mannitol-sucrose-glycerol lyophilizates.
Horn J; Schanda J; Friess W
Eur J Pharm Biopharm; 2018 Jun; 127():342-354. PubMed ID: 29522899
[TBL] [Abstract][Full Text] [Related]
19. Cake shrinkage during freeze drying: a combined experimental and theoretical study.
Rambhatla S; Obert JP; Luthra S; Bhugra C; Pikal MJ
Pharm Dev Technol; 2005; 10(1):33-40. PubMed ID: 15776811
[TBL] [Abstract][Full Text] [Related]
20. Quantitative risk assessment via uncertainty analysis in combination with error propagation for the determination of the dynamic Design Space of the primary drying step during freeze-drying.
Van Bockstal PJ; Mortier STFC; Corver J; Nopens I; Gernaey KV; De Beer T
Eur J Pharm Biopharm; 2017 Dec; 121():32-41. PubMed ID: 28927638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
